Biologics, Wound Care, Infection Prevention
Innovative Wound-Healing Could Save Human Limbs
The fight is on to save human limbs: As the rate of diabetes continues to rise, the foot ulcers and chronic wounds that can come with the condition — and can lead to amputations in severe cases — remain a persistent problem. To address it, medical professionals are now turning to wound dressings made from…
Read MoreWound Care BioActive to See Growth in Coming Years
Advanced wound dressing materials made from biomaterials play an important role in the wound healing process are known as bioactive wound care dressings. Bioactive wound care dressings also comprise tissue-engineered products derived from artificial sources or natural tissues. These are usually formed by combining various polymers such as collagen, hyaluronic acid, elastin, alginates and chitosan.…
Read MoreBSN medical Names Todd Healy President of North America
CHARLOTTE, NC–(Marketwired – Jan 11, 2016) –BSN medical, a leading global medical device manufacturer, today announced the appointment of Todd Healy as the organization’s president of North America, effective Jan. 15, 2016. With more than 30 years of experience in healthcare sales and operations, Healy joins BSN from Owens & Minor, Inc., a leading international…
Read MoreArtificial Pancreas Trials To Begin In The U.S.
In the U.S. alone, 1.25 million Americans suffer from type 1 diabetes, a potentially debilitating and life-changing condition. Every year, more and more people are diagnosed, and the only common treatment is regular insulin injections. A research team hoping to revolutionize diabetes treatment has developed an artificial pancreas that automatically detects changing blood sugar levels and…
Read MoreDressing for Disease Prevention Success
In the last couple decades, blood-borne diseases, like HIV, Hepatitis B and C and others have become a serious talking points – so much so that sharps safety has become an unofficial never event, double gloving is trending and OSHA requires facilities to provide fluid-resistant apparel to its staff. While sharps safety and double gloving…
Read MorePatient Hand Hygiene: The Missing Link
Abstract: Hospital acquired infections (HAI’s) are a major threat to patient safety and there is substantial evidence that good hand hygiene reduces the transmission of these diseases. However, most hand hygiene initiatives have focused on the role of the healthcare worker, caregiver, volunteer, etc. The role of the patient is often described in terms of…
Read MoreThis Is Why You Absolutely Need To Stop Wearing Shoes In Your House
Have you ever been to someone’s home and they have all the shoes by the front door outside of the house? I have had several friends mostly from eastern and/or Asian families who do this. I always found it interesting personally considering growing up not many of my friends and family kept all the shoes…
Read MoreXenex Wins 1st Place Infection Control ESP Award
Xenex Germ-Zapping Robot was awarded the first place Infection Control award in Surgical Products’ annual Excellence in Surgical Products Awards. To learn more about the product, Surgical Products connected with the experts at Xenex. Numerous studies have shown that standard cleaning practices leave contamination on OR surfaces that can contribute to Surgical Site Infections. Xenex’s pulsed xenon ultraviolet (UV) light disinfection technology…
Read MoreAcelity Aquires SNaP Therapy Systems from Spiracur
Acelity, a San Antonio-based global company focused on wound care and regenerative medicine, has acquired the SNaP Therapy System, a line of disposable negative pressure wound therapy products, from Spiracur. Terms of the deal were not disclosed. Spiracur is a privately held medical device company based in Sunnyvale, California. Its SNaP Therapy System is designed…
Read MoreFormer Biogen R&D Chief Resurfaces at $80M Startup Codiak Biosciences Pursuing Cancer, Alzheimer’s
Doug Williams left one of biotechnology’s biggest R&D jobs, at Biogen, in July. Now we know why. Williams is now the founding CEO of Codiak Biosciences, a Cambridge, Mass.-based startup. The little company is announcing today it has raised $80 million in committed venture capital spread over two installments. Two venture firms known for creating…
Read More